Loading live market data…

Humana Inc.

NYSE:HUM

$407.78 USD

$1.01 (0.25%)

Volume
1.56M
Average Volume
1.63M
Market Capitalization
$48.96B
P/E Ratio
43.47
Dividend Yield
0.87%
Price Target
$320.00
Year High
$415.00
Year Low
$163.11
Day High
Day Low
Payout Ratio
$0.38
Current Ratio
$1.26
Source Headline
Humana Eyes 3% Medicare Advantage Margin: Can It Deliver?

Humana targets a 3% Medicare Advantage margin by 2028 while pursuing 25% 2026 membership growth and rebuilding profitability despite industry headwinds.

zacks.com - 2026-07-13 13:40:22

Did Humana Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Did Humana Inc. Insiders Breach their Fiduciary Duties to Shareholders? PR Newswire NEW YORK, July 3, 2026

gurufocus.com - 2026-07-03 13:00:00

Did Humana Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

prnewswire.com - 2026-07-03 12:49:00

The Humana Foundation Deepens Investment in Emotional Health, Announcing Over $12 Million in New Grants

LOUISVILLE, Ky.--(BUSINESS WIRE)--The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE: HUM) for the past 45 years, today announced its first slate of 2026 grants, dedicating over $12.2 million to programs and research focused on emotional well-being. The funding will support 13 nonprofit organizations and five university research teams focused on combating loneliness, depression and social isolation among seniors and veterans nationwide. The 2026 national grants scale the Foundati.

businesswire.com - 2026-06-30 08:00:00

Dario Appoints Former Humana Chief Compliance Officer Sean O'Reilly to Advisory Board to Support Strategic Growth and Healthcare Partnerships

O'Reilly's extensive experience across healthcare compliance, risk management, regulatory oversight and payer operations expected to support Dario's continued expansion with health plans, employers and providers as Dario moves closer to care O'Reilly's track record of leveraging advanced data analytics and AI in supporting value-based care strongly aligned with Dario's AI transition NEW YORK, June 30, 2026 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) (the "Company", "DarioHealth" or "Dario"), a leader in AI-enabled digital health solutions, today announced the appointment of Sean O'Reilly to its Advisory Board. The appointment reflects Dario's continued focus on strengthening its strategic guidance as the Company advances its channel partner-led growth strategy and moves closer to care across the payer, provider and employer markets.

prnewswire.com - 2026-06-30 07:30:00

How CenterWell Is Driving Humana's Growth Beyond Insurance

CenterWell's rapid growth is helping HUM expand beyond insurance with integrated care, acquisitions, AI and a 2026 revenue target of at least $25B.

zacks.com - 2026-06-29 11:45:17

Swedish care provider Ambea makes recommended $304 million offer for Humana

Swedish care provider Ambea said on Monday it had made a recommended public ​offer for peer Humana , valuing the ‌company at about 2.96 billion Swedish crowns ($304.13 million).

reuters.com - 2026-06-29 01:56:20

Can Humana's Margin Recovery Drive Long-Term Earnings Growth?

HUM is shifting from membership growth to profitability, with lower medical costs, rising CenterWell revenues, and a margin recovery plan through 2028.

zacks.com - 2026-06-24 12:25:30

Humana Inc. (NYSE: HUM) Investor Alert: Schubert Jonckheer Investigating Possible False Statements Regarding Healthcare Utilization Costs, Over $104 Million Insider Sales

Humana Inc. (NYSE: HUM) Investor Alert: Schubert Jonckheer Investigating Possible False Statements Regarding Healthcare Utilization Costs, Over

gurufocus.com - 2026-06-23 13:00:00

Humana Inc. (NYSE: HUM) Investor Alert: Schubert Jonckheer Investigating Possible False Statements Regarding Healthcare Utilization Costs, Over $104 Million Insider Sales

SAN FRANCISCO, June 23, 2026 /PRNewswire/ -- Schubert Jonckheer & Kolbe LLP advises Humana Inc. (NYSE: HUM) investors that the firm is investigating potential legal claims arising from alleged false and misleading statements about the company's exposure to increased healthcare utilization costs. Current shareholders are encouraged to contact the firm here: https://www.classactionlawyers.com/humana.

prnewswire.com - 2026-06-23 12:00:00

Humana Inc. to Release Second Quarter 2026 Results on July 29, 2026

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) will release its financial results for the second quarter 2026 (2Q26), as well as prepared management remarks (in PDF format), at 6:00 a.m. Eastern time on July 29, 2026. The company will host a live question-and-answer session at 8:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2026. A webcast of the 2Q26 earnings call may be accessed via Humana's Investor Relations page at h.

businesswire.com - 2026-06-22 16:30:00

UnitedHealth vs. Humana: Which Healthcare Leader Is a Better Bet Now?

UNH's diversified platform, AI investments and stronger earnings outlook give it an edge over Medicare-focused rival HUM.

zacks.com - 2026-06-22 13:55:51

3 Stocks Doing the Heavy Lifting in Healthcare's Rebound

Until recently, it had been a lackluster year for the healthcare sector. From high medical utilization squeezing insurers to structural cost pressures and valuation hangovers, medical stocks stocks have lagged much of the broader market this year.

marketbeat.com - 2026-06-18 09:31:18

The Big 3: HUM, BAC, MSFT

​@Theotrade's Don Kaufman walks us through today's Big 3 and offers example options trades for his picks. He points to Humana (HUM) as a great bearish opportunity in the weeks to come, Bank of America (BAC) as a bullish opportunity into all-time high territory, and Microsoft (MSFT) not being able to shake bearish trends.

youtube.com - 2026-06-17 13:00:14

The Healthcare M&A Wave

In this week's edition of InnovationRx, we look at biotech M&A, the rise of India's Anthem Biosciences, and more. To get it in your inbox, subscribe here.

forbes.com - 2026-06-17 12:30:08

Humana Awarded Statewide Illinois HealthChoice Medicaid Contract, Expanding Access to Care Across the State

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Awarded Statewide Illinois HealthChoice Medicaid Contract, Expanding Access to Care Across the State.

businesswire.com - 2026-06-17 08:00:00

Humana, CenterWell and National Hispanic Medical Association Announce 2026 Resident Physician Scholarship Program Recipients

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana, CenterWell and National Hispanic Medical Association announce 2026 Resident Physician Scholarship Program recipients.

businesswire.com - 2026-06-16 07:00:00

Invesco's RSPH vs. PJP: Which Health Care ETF Is the Better Fund For The GLP-1 Revolution?

Compare portfolio strategies, cost structures, and risk profiles as two Invesco healthcare ETFs take different paths to sector exposure.

fool.com - 2026-06-15 16:42:41

Humana Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Humana Inc. - HUM

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF continues its investigation into Humana Inc. (“Humana” or “the Company”) (NYSE: HUM). On January 18, 2024, the Company announced its financial results for the fourth quarter and full year 2023, disclosing that its benefits expense ratio increased to approximately 91.4% for the fourth quarter of 2023 and approximately.

businesswire.com - 2026-06-15 13:38:00

Humana Closes the Kindred Chapter With $900 Million Gentiva Exit

HUM is cashing out its Gentiva stake for $900 million, completing a multiyear effort to sharpen focus on its core health insurance business.

zacks.com - 2026-06-11 14:21:03

Humana To Divest End-Of-Life Care Business For $900 Million

Humana, one of the nation's largest providers of privatized Medicare Advantage health insurance for older adults, announced plans to divest its minority stake in a provider of end-of-life services for $900 million.

forbes.com - 2026-06-10 18:30:41

Humana divests minority stake in hospice provider Gentiva

Humana said on Wednesday it has agreed to sell all or ​substantially all of its minority stake ‌in Gentiva, a provider of hospice and palliative care services, in a deal valuing the ​stake at about $900 million.

reuters.com - 2026-06-10 16:53:33

Humana Announces Agreement to Divest Minority Interest in Gentiva

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) today announced that it has signed a definitive agreement with a consortium of investors to divest all or substantially all of its minority interest in Gentiva, the nation's leading provider of end-of-life services, including hospice and palliative care. The agreement values Humana's minority interest stake at approximately $900 million. Other financial terms were not disclosed. Humana intends to utilize proceeds from the sale for genera.

businesswire.com - 2026-06-10 16:30:00

Humana and CenterWell Employees Donate More Than $1.4 Million in 24 Hours

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana and CenterWell employees combined to donate more than $1.4 million to nonprofit organizations in just 24 hours during the Humana Foundation's annual Double Match Day in April. During the event, more than 1,600 employees donated to a total of 1,650 nonprofits across the United States to support their communities. Since 2022, Humana and the Humana Foundation have contributed a combined $5.9 million in matching donations during Double Match Day. “Our employ.

businesswire.com - 2026-06-10 09:00:00

Trump's Economy Hired Nearly 1 Million Healthcare Workers While Every Other Sector Lost Jobs. Here's Where to Put Your Money

Economist Justin Wolfers dropped a number on the Prof G Markets podcast that should reorganize how you think about the 2026 economy.

247wallst.com - 2026-06-10 08:34:22

As Tech Stocks Slide, The Healthcare Sector Shines. Why Some Experts Say They Like This Defensive Play

Tech stocks are pulling back, and healthcare is surging.

investopedia.com - 2026-06-09 18:06:29

Medicare Advantage Continues To Grow Despite Health Insurer Exits

Despite some high-profile retreats by health insurers from Medicare Advantage, the privatized medical coverage for older adults continues to add health plan members and is now the choice of 55% of eligible beneficiaries, a new report shows.

forbes.com - 2026-06-07 08:25:08

Did Humana Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Did Humana Inc. Insiders Breach their Fiduciary Duties to Shareholders? PR Newswire NEW YORK, June 5, 2026

gurufocus.com - 2026-06-05 16:00:00

Did Humana Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

prnewswire.com - 2026-06-05 15:50:00

Humana Inc (HUM) Shares Surge 6.8% -- What GF Score of 86 Tells Investors

On June 04, 2026, Humana Inc (HUM) shares rose 6.8% to a current price of $349.80. The stock has seen significant price performance recently, with a 52-week ran

gurufocus.com - 2026-06-04 17:43:00

Humana Jumps 6%, UnitedHealth Climbs 5%, Cigna Rises 4% as Analysts Cheer Softer Medical Cost Trends

Health insurers are running higher in Thursday afternoon trading after a wave of bullish Wall Street analyst notes on the managed-care sector, centered on UnitedHealth, citing softer medical cost and utilization trends plus potential AI efficiency upside.

247wallst.com - 2026-06-04 13:32:55

5 HMO Stocks in Focus Amid an Aging U.S. Population, Tech Innovation

Aging demographics, sound Medicare premiums, digital healthcare adoption and increased M&A activity are likely to drive the performance of the Zacks Medical-HMO industry players. UNH, CI, HUM, CNC and MOH are poised to benefit from favorable industry prospects.

zacks.com - 2026-06-03 11:25:34

Humana Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Humana Inc. - HUM

Humana Investigation Continued: Kahn Swick and Foti, LLC Continues to Investigate the Officers and Directors of Humana Inc. - HUM

gurufocus.com - 2026-05-29 23:00:00

Humana Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Humana Inc. - HUM

NEW ORLEANS, May 29, 2026 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq.

prnewswire.com - 2026-05-29 22:00:00

Humana (HUM) Up 30.6% Since Last Earnings Report: Can It Continue?

Humana (HUM) reported earnings 30 days ago. What's next for the stock?

zacks.com - 2026-05-29 12:31:20

Humana completes $83 million Florida infrastructure investment to deepen coordinated patient care approach

ORLANDO, Fla.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM), one of the nation's leading health and well-being companies, today announced the start of full operations of its newest CenterWell Pharmacy® mail order distribution center, in Orlando, Florida. The $83 million, state-of-the-art facility bolsters capacity for prescription medication delivery across Florida and the country and reinforces Humana's longstanding commitment to providing members and patients across the Sunshine State with a simp.

businesswire.com - 2026-05-27 08:00:00

Congressional Joint Economic Committee Pegs Medicare Advantage Overpayments at $7 Billion Annually and Rising

According to Kiplinger, the Congressional Joint Economic Committee found Medicare Advantage is overpaying insurers by $212 per enrollee.

247wallst.com - 2026-05-22 13:30:35

Humana Just Got a Massive Upgrade From Deutsche Bank: Price Target Nearly Doubles to $441

Deutsche Bank just delivered one of the most aggressive analyst upgrades of 2026 on Humana (NYSE:HUM | HUM Price Prediction), lifting the managed care giant to Buy from Hold while nearly doubling its price target to $441 from $235.

247wallst.com - 2026-05-20 10:46:23

Here Are Wednesday’s Top Wall Street Analyst Research Calls: BJ’s Wholesale Club, Centene, Cigna, Crown Castle, ETSY, Franco-Nevada, Humana, Ovintiv, X-Energy, and More

Pre-Market Stock Futures: Futures are trading higher on the heels of the third straight day of stock declines, and there is growing apprehension that yields will go even higher and that inflation may as well. All of the major indices finished Tuesday lower, and with Q1 earnings all but over and the incoming economic data... Here Are Wednesday's Top Wall Street Analyst Research Calls: BJ's Wholesale Club, Centene, Cigna, Crown Castle, ETSY, Franco-Nevada, Humana, Ovintiv, X-Energy, and More

247wallst.com - 2026-05-20 07:59:49

Here's Why Investors Should Stay Neutral on Humana Stock for Now

HUM's Medicare growth, CenterWell expansion and strong cash flow support gains, but rising costs and high leverage keep caution in focus.

zacks.com - 2026-05-19 12:16:06

Humana Just Ripped 48% in a Month. Is It Outperforming Other Healthcare Stocks Like UnitedHealth and Cigna?

Shares of Humana (NYSE:HUM | HUM Price Prediction) are trading near $303 at midday Monday, slightly lower on the session after a flat open.

247wallst.com - 2026-05-18 14:48:21

Humana: Perhaps The 'Buy The Dip' Thesis Was Right All Along (Rating Upgrade)

Humana Inc. is upgraded to Buy as shares rebound from a >65% decline, supported by improved CMS rate decisions and activist investor involvement. Despite 2026 EPS guidance below Q1 levels, HUM targets a sustainable 3%+ Medicare Advantage margin and long-term earnings growth by 2028. Recent Q1 results exceeded revenue and adjusted EPS expectations, with a favorable medical benefit ratio and affirmed 25% MA membership growth for 2026.

seekingalpha.com - 2026-05-18 13:49:25

Humana Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Humana Inc. - HUM

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF continues its investigation into Humana Inc. (“Humana” or “the Company”) (NYSE: HUM). On January 18, 2024, the Company announced its financial results for the fourth quarter and full year 2023, disclosing that its benefits expense ratio increased to approximately 91.4% for the fourth quarter of 2023 and approximately.

businesswire.com - 2026-05-15 17:32:00

Piper Sandler Just Hiked Humana Price Target to $254: Medicare Advantage Beat Powers the Bull Case

Humana (NYSE:HUM | HUM Price Prediction) stock received a price target raise to $254 from $182 from Piper Sandler, which maintained a Neutral rating.

247wallst.com - 2026-05-13 11:06:34

Humana Invests More Than $1 Million to Advance Health Outcomes Across Louisiana

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana invests more than $1 million to advance health outcomes across Louisiana through grants that support statewide priorities.

businesswire.com - 2026-05-13 09:29:00

Diamond Hill Small-Mid Cap Strategy Q1 2026 Portfolio Activity

We do not believe Humana's current share price reflects the company's earnings power, and as industry conditions normalize, we believe it can return to target margins over the long term. We initiated a position in Antero Resources, a natural gas exploration and production company, to gain exposure given our constructive long-term outlook for US natural gas. We exited our position in First Advantage, a leader in the background check space, to pursue other opportunities with less macro exposure and AI-disruption concerns.

seekingalpha.com - 2026-05-07 12:27:00

Artisan Value Fund Q1 2026 Portfolio Activity

We initiated four new positions in Q1, an above-average pace of activity. We also used the increased volatility to upgrade overall portfolio quality. Our three largest new positions were Amazon.com, Universal Music Group and IQVIA Holdings. In addition to sales of Humana and PayPal, we also exited our positions in social technology leader Meta Platforms and beverages company Diageo.

seekingalpha.com - 2026-05-06 00:34:00

Did Humana Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

prnewswire.com - 2026-05-05 14:22:00

Florida Seniors Face High Rates of Poor Mental Health -- A Looming Crisis as State Braces for Aging Population Boom

LOUISVILLE, Ky.--(BUSINESS WIRE)--Florida ranks among the top three states in the nation for the largest senior population, with projections showing that one-third of its residents will be over 60 by 2050. However, a new research brief by the Humana Foundation, the philanthropic arm of Humana Inc. for the past 45 years, finds that a significant number of older Floridians are facing mental health challenges, many of which go unrecognized and unaddressed. The research brief, The State of Senior E.

businesswire.com - 2026-05-05 09:00:00

Major health insurers show signs of recovery – but a key test looms

Solid first-quarter results from major insurers like UnitedHealth, Elevance, Cigna and Humana have helped lift investor sentiment, even as insurers continue to grapple with higher medical costs. But analysts caution that insurers have incomplete data on medical costs in the first quarter due to a lag in claims processing, which sets up the second quarter as the real proving ground.

cnbc.com - 2026-05-05 07:00:01

Get HUM Insider Trade Alerts

HUM Price Target Summary

Last Month

$386.40

5 analysts

Last Quarter

$313.43

23 analysts

Last Year

$282.71

51 analysts

All Time

$371.69

104 analysts

HUM Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade
2026-07-14 Truist Securities Maintain Hold Hold
2026-07-14 TD Cowen Maintain Hold Hold
2026-07-13 Wells Fargo Upgrade Equal Weight Overweight
2026-07-09 RBC Capital Maintain Sector Perform Sector Perform
2026-07-07 Cantor Fitzgerald Maintain Neutral Neutral
2026-06-24 B of A Securities Maintain Neutral Neutral
2026-06-11 Evercore ISI Group Maintain In Line In Line
2026-06-08 JP Morgan Maintain Neutral Neutral
2026-06-08 Mizuho Maintain Outperform Outperform
2026-06-04 Morgan Stanley Maintain Underweight Underweight
2026-06-04 B of A Securities Maintain Neutral Neutral
2026-06-01 Truist Securities Maintain Hold Hold
2026-05-26 Barclays Maintain Equal Weight Equal Weight
2026-05-22 UBS Maintain Neutral Neutral
2026-05-20 Deutsche Bank Upgrade Hold Buy
2026-05-20 Mizuho Maintain Outperform Outperform
2026-05-15 Morgan Stanley Maintain Underweight Underweight
2026-05-13 Piper Sandler Maintain Neutral Neutral
2026-05-01 TD Cowen Maintain Hold Hold
2026-05-01 JP Morgan Maintain Neutral Neutral
2026-04-30 RBC Capital Maintain Sector Perform Sector Perform
2026-04-30 Truist Securities Maintain Hold Hold
2026-04-30 Guggenheim Maintain Buy Buy
2026-04-30 UBS Maintain Neutral Neutral
2026-04-30 Evercore ISI Group Maintain In Line In Line
2026-04-30 Barclays Maintain Equal Weight Equal Weight
2026-04-13 Truist Securities Maintain Hold Hold
2026-04-08 Evercore ISI Group Maintain In Line In Line
2026-04-07 Wells Fargo Maintain Equal Weight Equal Weight
2026-02-25 Barclays Maintain Equal Weight Equal Weight
2026-02-18 Wells Fargo Maintain Equal Weight Equal Weight
2026-02-17 Truist Securities Maintain Hold Hold
2026-02-17 Goldman Sachs Maintain Sell Sell
2026-02-13 TD Cowen Maintain Hold Hold
2026-02-12 Guggenheim Maintain Buy Buy
2026-02-12 UBS Maintain Neutral Neutral
2026-02-12 Jefferies Maintain Buy Buy
2026-02-12 RBC Capital Downgrade Outperform Sector Perform
2026-02-12 Cantor Fitzgerald Maintain Neutral Neutral
2026-02-02 Morgan Stanley Downgrade Equal Weight Underweight
2026-01-07 Wells Fargo Downgrade Overweight Equal Weight
2026-01-05 Barclays Maintain Equal Weight Equal Weight
2025-12-18 Morgan Stanley Maintain Equal Weight Equal Weight
2025-12-05 Jefferies Upgrade Hold Buy
2025-11-25 Barclays Maintain Equal Weight Equal Weight
2025-11-10 Truist Securities Maintain Hold Hold
2025-11-07 Deutsche Bank Maintain Hold Hold
2025-10-10 B of A Securities Maintain Neutral Neutral
2025-10-09 Mizuho Maintain Outperform Outperform
2025-10-07 Wells Fargo Maintain Overweight Overweight
2025-10-03 Guggenheim Maintain Buy Buy
2025-10-03 Barclays Maintain Equal Weight Equal Weight
2025-09-05 Bernstein Maintain Outperform Outperform
2025-09-05 Barclays Maintain Equal Weight Equal Weight
2025-09-02 B of A Securities Maintain Neutral Neutral
2025-08-21 RBC Capital Maintain Outperform Outperform
2025-08-14 Wells Fargo Maintain Overweight Overweight
2025-08-14 Argus Research Maintain Hold Hold
2025-07-31 Morgan Stanley Maintain Equal Weight Equal Weight
2025-07-31 Piper Sandler Maintain Neutral Neutral
2025-07-31 Barclays Maintain Equal Weight Equal Weight
2025-07-25 Baird Maintain Neutral Neutral
2025-07-16 Truist Securities Maintain Hold Hold
2025-06-17 B of A Securities Maintain Neutral Neutral
2025-06-17 Truist Securities Maintain Hold Hold
2025-06-12 Barclays Maintain Equal Weight Equal Weight
2025-06-02 Barclays Maintain Equal Weight Equal Weight
2025-05-12 Truist Securities Maintain Hold Hold
2025-05-01 Cantor Fitzgerald Maintain Neutral Neutral
2025-05-01 Oppenheimer Maintain Outperform Outperform
2025-04-15 Baird Maintain Neutral Neutral
2025-04-11 Truist Securities Maintain Hold Hold
2025-04-11 Barclays Maintain Equal Weight Equal Weight
2025-04-09 Mizuho Maintain Outperform Outperform
2025-02-18 JP Morgan Maintain Neutral Neutral
2025-02-13 Barclays Maintain Equal Weight Equal Weight
2025-02-12 RBC Capital Maintain Outperform Outperform
2025-02-12 Morgan Stanley Maintain Equal Weight Equal Weight
2025-02-12 Cantor Fitzgerald Maintain Neutral Neutral
2025-01-22 Barclays Maintain Equal Weight Equal Weight
2025-01-15 Piper Sandler Maintain Neutral Neutral
2025-01-06 Truist Securities Maintain Hold Hold
2024-12-17 Morgan Stanley Maintain Equal Weight Equal Weight
2024-11-06 B of A Securities Upgrade Underperform Neutral
2024-11-04 Wells Fargo Maintain Overweight Overweight
2024-11-04 TD Cowen Maintain Hold Hold
2024-10-31 Barclays Maintain Equal Weight Equal Weight
2024-10-11 Truist Securities Maintain Hold Hold
2024-10-10 Barclays Maintain Equal Weight Equal Weight
2024-10-09 Stephens & Co. Maintain Equal Weight Equal Weight
2024-10-08 Bernstein Upgrade Market Perform Outperform
2024-10-08 RBC Capital Maintain Outperform Outperform
2024-10-07 Jefferies Downgrade Buy Hold
2024-10-07 TD Cowen Downgrade Buy Hold
2024-10-04 UBS Maintain Neutral Neutral
2024-10-03 Piper Sandler Downgrade Overweight Neutral
2024-10-03 Oppenheimer Maintain Outperform Outperform
2024-10-03 Deutsche Bank Maintain Hold Hold
2024-10-02 Stephens & Co. Downgrade Overweight Equal Weight
2024-10-02 B of A Securities Downgrade Neutral Underperform
2024-10-02 Leerink Partners Downgrade Outperform Market Perform
2024-10-01 Cantor Fitzgerald Maintain Neutral Neutral
2024-09-20 Cantor Fitzgerald Maintain Neutral Neutral
2024-09-10 Cantor Fitzgerald Maintain Neutral Neutral
2024-09-05 RBC Capital Maintain Outperform Outperform
2024-08-21 JP Morgan Maintain Neutral Neutral
2024-08-19 Cantor Fitzgerald Maintain Neutral Neutral
2024-08-02 Deutsche Bank Maintain Hold Hold
2024-08-01 Barclays Maintain Equal Weight Equal Weight
2024-08-01 Oppenheimer Maintain Outperform Outperform
2024-07-24 TD Cowen Maintain Buy Buy
2024-07-23 Cantor Fitzgerald Maintain Neutral Neutral
2024-07-15 Truist Securities Maintain Hold Hold
2024-06-12 Cantor Fitzgerald Maintain Neutral Neutral
2024-05-20 B of A Securities Maintain Neutral Neutral
2024-04-25 UBS Maintain Neutral Neutral
2024-04-25 Cantor Fitzgerald Maintain Neutral Neutral
2024-04-25 RBC Capital Maintain Outperform Outperform
2024-04-25 Oppenheimer Maintain Outperform Outperform
2024-04-22 Jefferies Maintain Buy Buy
2024-04-10 Cantor Fitzgerald Maintain Neutral Neutral
2024-04-08 Wells Fargo Maintain Overweight Overweight
2024-04-04 Cantor Fitzgerald Maintain Neutral Neutral
2024-04-03 Goldman Sachs Maintain Buy Buy
2024-04-02 Barclays Maintain Equal Weight Equal Weight
2024-04-02 B of A Securities Downgrade Buy Neutral
2024-04-02 TD Cowen Maintain Buy Buy
2024-03-13 Argus Research Downgrade Buy Hold
2024-01-30 Wells Fargo Maintain Overweight Overweight
2024-01-29 Goldman Sachs Maintain Buy Buy
2024-01-26 Stephens & Co. Maintain Overweight Overweight
2024-01-26 Cantor Fitzgerald Downgrade Overweight Neutral
2024-01-26 Mizuho Maintain Buy Buy
2024-01-26 UBS Downgrade Buy Neutral
2024-01-26 RBC Capital Maintain Outperform Outperform
2024-01-26 Goldman Sachs Maintain Buy Buy
2024-01-25 Deutsche Bank Downgrade Buy Hold
2024-01-19 Goldman Sachs Maintain Buy Buy
2024-01-19 Truist Securities Maintain Hold Hold
2024-01-19 Cantor Fitzgerald Maintain Overweight Overweight
2024-01-19 RBC Capital Maintain Outperform Outperform
2024-01-17 Oppenheimer Maintain Outperform Outperform
2023-12-12 Argus Research Upgrade Hold Buy
2023-11-21 Cantor Fitzgerald Maintain Overweight Overweight
2023-11-17 JP Morgan Maintain Neutral Neutral
2023-11-02 Stephens & Co. Maintain Overweight Overweight
2023-11-02 Cantor Fitzgerald Maintain Overweight Overweight
2023-11-02 RBC Capital Maintain Outperform Outperform
2023-10-09 Jefferies Maintain Buy Buy
2023-09-14 Cantor Fitzgerald Maintain Overweight Overweight
2023-08-30 Morgan Stanley Maintain Overweight Overweight
2023-08-15 TD Cowen Maintain Outperform Outperform
2023-08-08 Bernstein Maintain Market Perform Market Perform
2023-08-07 Deutsche Bank Maintain Buy Buy
2023-08-03 Truist Securities Maintain Hold Hold
2023-08-03 Stephens & Co. Maintain Overweight Overweight
2023-08-03 RBC Capital Maintain Outperform Outperform
2023-07-14 Morgan Stanley Maintain Overweight Overweight
2023-07-13 Wells Fargo Maintain Overweight Overweight
2023-07-13 UBS Maintain Buy Buy
2023-07-11 Mizuho Maintain Buy Buy
2023-07-07 JP Morgan Downgrade Overweight Neutral
2023-06-23 Argus Research Downgrade Buy Hold
2023-06-20 Truist Securities Maintain Hold Hold
2023-06-20 RBC Capital Maintain Outperform Outperform
2023-06-15 RBC Capital Maintain Outperform Outperform
2023-05-30 JP Morgan Maintain Overweight Overweight
2023-05-02 TD Cowen Maintain Outperform Outperform
2023-04-27 SVB Securities Maintain Outperform Outperform
2023-04-13 Truist Securities Maintain Hold Hold
2023-04-11 Morgan Stanley Maintain Overweight Overweight
2023-02-28 Deutsche Bank Maintain Buy Buy
2023-02-07 Truist Securities Maintain Hold Hold
2023-02-06 Cowen & Co. Maintain Outperform Outperform
2023-02-06 Credit Suisse Maintain Outperform Outperform
2023-02-03 Stephens & Co. Maintain Overweight Overweight
2023-02-02 UBS Maintain Buy Buy
2023-01-06 JP Morgan Maintain Overweight Overweight
2022-12-13 Goldman Sachs Upgrade Neutral Buy
2022-11-10 Mizuho Maintain Buy Buy
2022-11-03 Credit Suisse Maintain Outperform Outperform
2022-11-03 SVB Leerink Maintain Outperform Outperform
2022-11-03 RBC Capital Maintain Outperform Outperform
2022-11-03 Goldman Sachs Maintain Neutral Neutral
2022-10-31 Morgan Stanley Maintain Overweight Overweight
2022-10-26 Deutsche Bank Upgrade Hold Buy
2022-09-20 RBC Capital Maintain Outperform Outperform
2022-09-20 Morgan Stanley Upgrade Equal Weight Overweight
2022-09-16 Truist Securities Maintain Hold Hold
2022-09-16 Oppenheimer Maintain Outperform Outperform
2022-08-02 Morgan Stanley Maintain Equal Weight Equal Weight
2022-07-28 Barclays Maintain Overweight Overweight
2022-07-28 Oppenheimer Maintain Outperform Outperform
2022-07-28 Mizuho Maintain Buy Buy
2022-07-28 SVB Leerink Maintain Outperform Outperform
2022-07-14 Truist Securities Maintain Hold Hold
2022-05-25 Wells Fargo Maintain Overweight Overweight
2022-04-28 Wells Fargo Maintain Overweight Overweight
2022-04-28 RBC Capital Maintain Outperform Outperform
2022-04-28 SVB Leerink Maintain Outperform Outperform
2022-04-13 UBS Upgrade Neutral Buy
2022-03-09 Morgan Stanley Maintain Equal Weight Equal Weight
2022-02-03 SVB Leerink Maintain Outperform Outperform
2022-01-07 Morgan Stanley Maintain Equal Weight Equal Weight
2022-01-07 Barclays Maintain Overweight Overweight
2022-01-07 Wells Fargo Maintain Overweight Overweight
2022-01-06 Wells Fargo Upgrade Equal Weight Overweight
2022-01-05 Truist Securities Maintain Hold Hold
2021-12-17 Morgan Stanley Downgrade Overweight Equal Weight
2021-12-16 Morgan Stanley Downgrade Overweight Equal Weight
2021-11-10 Deutsche Bank Maintain Hold Hold
2021-11-10 Mizuho Maintain Buy Buy
2021-11-04 Barclays Maintain Overweight Overweight
2021-11-04 Credit Suisse Maintain Outperform Outperform
2021-11-04 Morgan Stanley Maintain Overweight Overweight
2021-11-04 RBC Capital Maintain Outperform Outperform
2021-11-04 Oppenheimer Maintain Outperform Outperform
2021-11-04 SVB Leerink Maintain Outperform Outperform
2021-08-31 Morgan Stanley Maintain Overweight Overweight
2021-04-29 Citigroup Maintain Buy Buy
2021-04-29 Oppenheimer Maintain Outperform Outperform
2021-01-04 RBC Capital Upgrade Sector Perform Outperform
2020-11-30 SVB Leerink Maintain Outperform Outperform
2020-11-04 Credit Suisse Maintain Outperform Outperform
2020-10-01 Piper Sandler Maintain Overweight Overweight
2020-09-10 Deutsche Bank Maintain Hold Hold
2020-08-06 Piper Sandler Maintain Overweight Overweight
2020-08-06 SVB Leerink Maintain Outperform Outperform
2020-06-16 Cowen & Co. Downgrade Outperform Market Perform
2020-05-21 SunTrust Robinson Humphrey Maintain Hold Hold
2020-04-30 Morgan Stanley Maintain Overweight Overweight
2020-04-30 Credit Suisse Maintain Outperform Outperform
2020-04-30 Oppenheimer Maintain Outperform Outperform
2020-04-30 Citigroup Maintain Buy Buy
2020-04-13 Morgan Stanley Maintain Overweight Overweight
2020-03-27 Morgan Stanley Maintain Overweight Overweight
2020-02-18 Deutsche Bank Maintain Hold Hold
2020-02-06 Mizuho Maintain Buy Buy
2020-02-06 Deutsche Bank Maintain Buy Buy
2020-02-06 Morgan Stanley Maintain Overweight Overweight
2020-01-23 UBS Maintain Neutral Neutral
2020-01-08 Credit Suisse Maintain Outperform Outperform
2020-01-03 Goldman Sachs Maintain Buy Buy
2020-01-03 JP Morgan Maintain Overweight Overweight
2019-12-20 JP Morgan Maintain Overweight Overweight
2019-12-18 SunTrust Robinson Humphrey Maintain Hold Hold
2019-12-11 Wells Fargo Maintain Overweight Overweight
2019-12-06 Barclays Maintain Overweight Overweight
2019-11-18 Morgan Stanley Maintain Overweight Overweight
2019-11-18 SunTrust Robinson Humphrey Maintain Hold Hold
2019-11-12 UBS Maintain Neutral Neutral
2019-11-07 Citigroup Maintain Buy Buy
2019-09-30 BMO Capital Downgrade Outperform Market Perform
2019-09-26 Morgan Stanley Maintain Overweight Overweight
2019-08-23 Morgan Stanley Maintain Overweight Overweight
2019-08-12 Cantor Fitzgerald Upgrade Neutral Overweight
2019-08-01 Piper Jaffray Maintain Overweight Overweight
2019-08-01 JP Morgan Maintain Overweight Overweight
2019-08-01 Piper Sandler Maintain Overweight Overweight
2019-08-01 UBS Maintain Neutral Neutral
2019-07-12 Morgan Stanley Maintain Overweight Overweight
2019-05-02 Citigroup Maintain Buy Buy
2019-04-17 Barclays Maintain Overweight Overweight
2019-02-07 Citigroup Maintain Buy Buy
2019-01-11 Cowen & Co. Upgrade Market Perform Outperform
2018-12-20 JP Morgan Upgrade Neutral Overweight
2018-11-08 Credit Suisse Maintain Outperform Outperform
2018-11-08 Morgan Stanley Maintain Overweight Overweight
2018-11-08 Jefferies Maintain Buy Buy
2018-11-08 RBC Capital Maintain Sector Perform Sector Perform
2018-09-05 Morgan Stanley Maintain Overweight Overweight
2018-08-02 Morgan Stanley Maintain Overweight Overweight
2018-08-02 Jefferies Maintain Buy Buy
2018-08-02 Bank of America Maintain Buy Buy
2018-08-02 B of A Securities Maintain Buy Buy
2018-06-25 BMO Capital Maintain Outperform Outperform
2018-05-05 Argus Downgrade Buy Hold
2018-05-05 Argus Maintain Buy Buy
2018-04-16 Argus Research Maintain Buy Buy
2018-04-16 Argus Maintain Buy Buy
2018-02-12 JP Morgan Maintain Neutral Neutral
2018-02-09 Deutsche Bank Maintain Hold Hold
2018-02-08 Credit Suisse Upgrade Neutral Outperform
2018-01-12 Jefferies Upgrade Hold Buy
2017-11-10 BMO Capital Maintain Outperform Outperform
2017-11-10 Credit Suisse Maintain Neutral Neutral
2017-11-09 Morgan Stanley Maintain Overweight Overweight
2017-10-09 JP Morgan Downgrade Overweight Neutral
2017-08-17 Morgan Stanley Maintain Overweight Overweight
2017-08-07 Deutsche Bank Maintain Hold Hold
2017-07-14 B of A Securities Maintain Buy Buy
2017-07-14 Bank of America Maintain Buy Buy
2017-06-09 Argus Upgrade Hold Buy
2017-06-09 Argus Research Upgrade Hold Buy
2017-04-21 Jefferies Downgrade Buy Hold
2017-01-24 Stifel Downgrade Buy Hold
2017-01-24 Stifel Nicolaus Downgrade Buy Hold
2016-12-07 Cantor Fitzgerald Downgrade Buy Hold
2016-11-11 Credit Suisse Upgrade Neutral Outperform
2016-11-10 JP Morgan Upgrade Neutral Overweight
2016-08-16 Credit Suisse Maintain Neutral Neutral
2016-08-04 Barclays Maintain Equal Weight Equal Weight
2016-08-04 Jefferies Maintain Buy Buy
2016-07-21 Credit Suisse Maintain Neutral Neutral
2016-07-18 Jefferies Upgrade Hold Buy
2015-09-08 RBC Capital Maintain Sector Perform Sector Perform
2015-07-09 Susquehanna Maintain Neutral Neutral
2015-07-07 Argus Downgrade Buy Hold
2015-07-07 Argus Research Downgrade Buy Hold
2015-07-06 Wedbush Downgrade Outperform Neutral
2015-07-02 Argus Maintain Buy Buy
2015-07-02 Argus Research Maintain Buy Buy
2015-06-03 Sterne Agee Upgrade Underperform Neutral
2015-06-03 Sterne Agee CRT Upgrade Underperform Neutral
2015-06-01 Leerink Swann Maintain Outperform Outperform
2015-06-01 Cantor Fitzgerald Maintain Buy Buy
2015-05-31 Deutsche Bank Maintain Hold Hold
2015-05-13 Sterne Agee CRT Downgrade Neutral Underperform
2015-05-13 Sterne Agee Downgrade Neutral Underperform
2015-05-07 Leerink Swann Maintain Outperform Outperform
2015-05-01 Oppenheimer Maintain Outperform Outperform
2015-04-30 Deutsche Bank Maintain Hold Hold
2015-04-29 Barclays Maintain Equal Weight Equal Weight
2015-04-29 Jefferies Maintain Hold Hold
2015-03-20 Barclays Maintain Equal Weight Equal Weight
2015-01-08 Barclays Maintain Equal Weight Equal Weight
2015-01-06 Deutsche Bank Upgrade Sell Hold
2015-01-05 Raymond James Downgrade Outperform Market Perform
2014-12-05 B of A Securities Maintain Neutral Neutral
2014-12-05 Bank of America Maintain Neutral Neutral
2014-12-05 JP Morgan Maintain Overweight Overweight
2014-11-18 B of A Securities Maintain Neutral Neutral
2014-11-18 Bank of America Maintain Neutral Neutral
2014-11-11 Citigroup Maintain Sell Sell
2014-11-10 Credit Suisse Maintain Neutral Neutral
2014-11-10 FBR Capital Maintain Market Perform Market Perform
2014-11-09 Barclays Maintain Equal Weight Equal Weight
2014-11-07 Goldman Sachs Upgrade Sell Neutral
2014-09-22 Citigroup Maintain Sell Sell
2014-09-19 JP Morgan Maintain Overweight Overweight
2014-08-07 Raymond James Maintain Outperform Outperform
2014-07-31 Barclays Maintain Equal Weight Equal Weight
2014-07-31 Credit Suisse Maintain Neutral Neutral
2014-07-16 Deutsche Bank Maintain Sell Sell
2014-06-06 Stifel Upgrade Hold Buy
2014-05-23 Leerink Swann Maintain Outperform Outperform
2014-05-22 Argus Research Maintain Buy Buy
2014-05-22 Argus Maintain Buy Buy
2014-05-09 Raymond James Maintain Outperform Outperform
2014-05-08 Bank of America Maintain Neutral Neutral
2014-05-08 Barclays Maintain Equal Weight Equal Weight
2014-05-08 B of A Securities Maintain Neutral Neutral
2014-05-08 FBR Capital Maintain Market Perform Market Perform
2014-05-08 Credit Suisse Maintain Neutral Neutral
2014-03-07 Jefferies Downgrade Buy Hold
2014-02-26 Citigroup Downgrade Neutral Sell
2014-01-08 Barclays Downgrade Overweight Equal Weight
2014-01-07 Deutsche Bank Downgrade Hold Sell
2013-11-20 JP Morgan Maintain Overweight Overweight
2013-11-07 Jefferies Maintain Buy Buy
2013-11-07 Deutsche Bank Maintain Hold Hold
2013-11-05 Monness Crespi Hardt Downgrade Buy Neutral
2013-11-05 Monness, Crespi, Hardt Downgrade Buy Neutral
2013-10-08 Deutsche Bank Maintain Hold Hold
2013-09-05 JP Morgan Maintain Overweight Overweight
2013-08-01 Jefferies Maintain Buy Buy
2013-08-01 Citigroup Downgrade Buy Neutral
2013-08-01 Stifel Nicolaus Downgrade Buy Hold
2013-08-01 Stifel Downgrade Buy Hold
2013-07-31 Monness, Crespi, Hardt Maintain Buy Buy
2013-07-31 Monness Crespi Hardt Maintain Buy Buy
2013-07-16 Deutsche Bank Maintain Hold Hold
2013-07-10 Jefferies Maintain Buy Buy
2013-05-10 Monness, Crespi, Hardt Maintain Buy Buy
2013-05-10 Monness Crespi Hardt Maintain Buy Buy
2013-05-06 JP Morgan Upgrade Neutral Overweight
2013-04-02 Deutsche Bank Maintain Hold Hold
2013-04-02 Jefferies Maintain Buy Buy
2013-02-26 Deutsche Bank Maintain Hold Hold
2013-02-05 Deutsche Bank Maintain Hold Hold
2013-02-05 Jefferies Maintain Buy Buy
2013-02-05 BMO Capital Maintain Market Perform Market Perform
2013-02-04 B of A Securities Maintain Neutral Neutral
2013-02-04 Bank of America Maintain Neutral Neutral
2012-11-13 B of A Securities Downgrade Buy Neutral
2012-11-13 Bank of America Downgrade Buy Neutral
2012-11-07 B of A Securities Downgrade Buy Neutral
2012-11-07 Bank of America Downgrade Buy Neutral
2012-11-07 Goldman Sachs Downgrade Neutral Sell
2012-11-06 BMO Capital Maintain Market Perform Market Perform
2012-11-06 Jefferies Maintain Buy Buy
2012-11-06 Credit Suisse Maintain Neutral Neutral
2012-11-05 Monness, Crespi, Hardt Maintain Buy Buy
2012-11-05 Monness Crespi Hardt Maintain Buy Buy
2012-10-15 Deutsche Bank Maintain Hold Hold
2012-08-30 Credit Suisse Downgrade Outperform Neutral
2012-07-31 Bank of America Maintain Buy Buy
2012-07-31 Goldman Sachs Maintain Neutral Neutral
2012-07-31 Barclays Maintain Equal Weight Equal Weight
2012-07-31 Stifel Nicolaus Maintain Buy Buy
2012-07-31 B of A Securities Maintain Buy Buy
2012-07-31 Deutsche Bank Maintain Hold Hold
2012-07-31 Stifel Maintain Buy Buy
2012-07-30 Citigroup Maintain Buy Buy
2012-05-01 Deutsche Bank Maintain Hold Hold
2012-05-01 Jefferies Maintain Buy Buy
2012-02-27 Credit Suisse Maintain Outperform Outperform